Role of a Novel E3-Ubiquitin Ligase in Chemoprevention
新型 E3-泛素连接酶在化学预防中的作用
基本信息
- 批准号:7846963
- 负责人:
- 金额:$ 53.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-09-30 至 2011-04-30
- 项目状态:已结题
- 来源:
- 关键词:Adaptor Signaling ProteinAmino AcidsAxonal NeuropathyBTB/POZ DomainBindingBiological ModelsBiological ProcessBroccoli - dietaryC-terminalCarcinogensCardiovascular DiseasesCell NucleusCell physiologyCellsChemicalsChemopreventionChemopreventive AgentComplexCytoplasmDNA DamageDataDiseaseEnzyme InductionEnzymesFoodGene TargetingGenesGenetic ProgrammingGenetic TranscriptionGlioblastomaGlutathioneHealthHomeostasisHumanIsothiocyanatesMalignant - descriptorMalignant NeoplasmsMalignant neoplasm of brainMediatingModelingMuscular AtrophyMutationN-terminalNF-E2-related factor 2Nerve DegenerationNeuropathyOxidation-ReductionOxidative StressPathway interactionsPeptidesPharmaceutical PreparationsPost-Translational Protein ProcessingPreventiveProteinsPublishingRepressionResearchRoleSignal Transduction PathwaySkeletal MuscleSpecificityStructureSulforaphaneUbiquitinUbiquitinationWorkbasecancer preventioncancer riskdesigndietary supplementsdriving forcefruits and vegetablesinsightnovelreconstitutionresearch studytranscription factorubiquitin ligaseubiquitin-protein ligase
项目摘要
The work in this proposal is focused on a major cancer-preventive signal transduction pathway that triggers
transcriptional induction of enzymes that protect cells from reactive chemical species, including carcinogens
and oxidative stress. This pathway is activated by both naturally occuring chemopreventive agents found in
a wide variety of fruits and vegetables and by synthetic molecules. We believe that a fundamental
understanding of this signal transduction pathway will facilitate the identification of foods, dietary
supplements and drugs that will significantly decrease the risk of cancer in humans. Furthermore, as
oxidative stress is a driving force of many pathophysiological conditions, including neurodegeneration,
cardiovascular disease and skeletal muscle atrophy,the proposed research will have a broad impact on
human health.
The critical target of this pathway, the transcription factor Nrf2, is normally repressed by the BTB-Kelch
protein, Keapl. Chemopreventive agents enable Nrf2 to escape Keapl-mediated repression andactivate
transcription of its target genes that eliminate reactive species and restore cellular redox homeostasis.
Our preliminary data suggest the hypothesis that Keapl functions as a substrate adaptor protein for a Cul3-
dependent E3 ubiquitin ligase complex. This hypothesis represents a new paradigm for understanding how
Keapl is able to repress Nrf2-dependent transcription and provides a productive framework for defining how
chemopreventive agents enable Nrf2 to escape Keapl-mediated repression. This hypothesis also provides
novel insight into the biological functions of all BTB-Kelch proteins. We propose to examine this hypothesis
further by characterizing disease-associated mutations within GAN1 and ENC1 that are responsible for giant
axonal neuropathy and contribute to brain cancers, respectively.
The proposed experiments will (1) define how Nrf2 is targeted for ubiquitin-dependent degradation by a
Keapl :Cul3:Rbx1 complex, (2) define how Nrf2 escapes Keapl-mediated repression, (3) use Keapl as a
model system to define how disease-associated mutations perturb the substrate adaptor function of BTB-
Kelch proteins, and (4) define the structural basis for substrate recognition by Keapl.
该提案的工作重点是一个主要的癌症预防信号转导途径,该途径触发
保护细胞免受活性化学物质(包括致癌物)侵害的酶的转录诱导
和氧化应激。该途径由两种天然存在的化学预防剂激活
多种水果和蔬菜以及合成分子。我们相信,一个根本的
了解这一信号转导途径将有助于识别食物、膳食
补充剂和药物将显着降低人类患癌症的风险。此外,如
氧化应激是许多病理生理状况的驱动力,包括神经变性、
心血管疾病和骨骼肌萎缩,所提出的研究将对
人类健康。
该通路的关键靶标转录因子 Nrf2 通常受到 BTB-Kelch 的抑制
蛋白质,凯普尔。化学预防剂使 Nrf2 能够逃脱 Keapl 介导的抑制并激活
其目标基因的转录消除活性物质并恢复细胞氧化还原稳态。
我们的初步数据表明,Keapl 的功能是作为 Cul3- 的底物衔接蛋白。
依赖的 E3 泛素连接酶复合物。这个假设代表了理解如何
Keapl 能够抑制 Nrf2 依赖性转录,并为定义如何抑制 Nrf2 转录提供了一个富有成效的框架
化学预防剂使 Nrf2 能够逃避 Keapl 介导的抑制。这个假设还提供了
对所有 BTB-Kelch 蛋白的生物学功能的新见解。我们建议检验这个假设
进一步描述了 GAN1 和 ENC1 中与疾病相关的突变,这些突变负责巨
分别导致轴突神经病变和脑癌。
拟议的实验将 (1) 定义 Nrf2 如何通过泛素依赖性降解来靶向
Keapl :Cul3:Rbx1 复合体,(2) 定义 Nrf2 如何逃避 Keapl 介导的抑制,(3) 使用 Keapl 作为
模型系统来定义疾病相关突变如何扰乱 BTB- 的底物接头功能
Kelch 蛋白,(4) 定义了 Keapl 底物识别的结构基础。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK HANNINK其他文献
MARK HANNINK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK HANNINK', 18)}}的其他基金
IMSD: An Initiative to Maximize Student Development in Biomedical Research at MU
IMSD:一项旨在最大限度地提高密苏里大学生物医学研究学生发展的计划
- 批准号:
10333313 - 财政年份:2020
- 资助金额:
$ 53.58万 - 项目类别:
IMSD: An Initiative to Maximize Student Development in Biomedical Research at MU
IMSD:一项旨在最大限度地提高密苏里大学生物医学研究学生发展的计划
- 批准号:
10093103 - 财政年份:2020
- 资助金额:
$ 53.58万 - 项目类别:
Molecular Basis of Gene Expression and Signal Processing
基因表达和信号处理的分子基础
- 批准号:
7890788 - 财政年份:2009
- 资助金额:
$ 53.58万 - 项目类别:
Role of a Novel E3-Ubiquitin Ligase in Chemoprevention
新型 E3-泛素连接酶在化学预防中的作用
- 批准号:
7405431 - 财政年份:2006
- 资助金额:
$ 53.58万 - 项目类别:
Role of a Novel E3-Ubiquitin Ligase in Chemoprevention
新型 E3-泛素连接酶在化学预防中的作用
- 批准号:
7093199 - 财政年份:2006
- 资助金额:
$ 53.58万 - 项目类别:
Role of a Novel E3-Ubiquitin Ligase in Chemoprevention
新型 E3-泛素连接酶在化学预防中的作用
- 批准号:
7226739 - 财政年份:2006
- 资助金额:
$ 53.58万 - 项目类别:
Role of a Novel E3-Ubiquitin Ligase in Chemoprevention
新型 E3-泛素连接酶在化学预防中的作用
- 批准号:
7595852 - 财政年份:2006
- 资助金额:
$ 53.58万 - 项目类别:
Oxidative stress, apoptosis, and germ cell development
氧化应激、细胞凋亡和生殖细胞发育
- 批准号:
6492428 - 财政年份:2002
- 资助金额:
$ 53.58万 - 项目类别:
Oxidative stress, apoptosis, and germ cell development
氧化应激、细胞凋亡和生殖细胞发育
- 批准号:
6627739 - 财政年份:2002
- 资助金额:
$ 53.58万 - 项目类别:
相似海外基金
Double Incorporation of Non-Canonical Amino Acids in an Animal and its Application for Precise and Independent Optical Control of Two Target Genes
动物体内非规范氨基酸的双重掺入及其在两个靶基因精确独立光学控制中的应用
- 批准号:
BB/Y006380/1 - 财政年份:2024
- 资助金额:
$ 53.58万 - 项目类别:
Research Grant
Quantifying L-amino acids in Ryugu to constrain the source of L-amino acids in life on Earth
量化 Ryugu 中的 L-氨基酸以限制地球生命中 L-氨基酸的来源
- 批准号:
24K17112 - 财政年份:2024
- 资助金额:
$ 53.58万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: RUI: Elucidating Design Rules for non-NRPS Incorporation of Amino Acids on Polyketide Scaffolds
合作研究:RUI:阐明聚酮化合物支架上非 NRPS 氨基酸掺入的设计规则
- 批准号:
2300890 - 财政年份:2023
- 资助金额:
$ 53.58万 - 项目类别:
Continuing Grant
Basic research toward therapeutic strategies for stress-induced chronic pain with non-natural amino acids
非天然氨基酸治疗应激性慢性疼痛策略的基础研究
- 批准号:
23K06918 - 财政年份:2023
- 资助金额:
$ 53.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms how arrestins that modulate localization of glucose transporters are phosphorylated in response to amino acids
调节葡萄糖转运蛋白定位的抑制蛋白如何响应氨基酸而被磷酸化的分子机制
- 批准号:
23K05758 - 财政年份:2023
- 资助金额:
$ 53.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular recognition and enantioselective reaction of amino acids
氨基酸的分子识别和对映选择性反应
- 批准号:
23K04668 - 财政年份:2023
- 资助金额:
$ 53.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Design and Synthesis of Fluorescent Amino Acids: Novel Tools for Biological Imaging
荧光氨基酸的设计与合成:生物成像的新工具
- 批准号:
2888395 - 财政年份:2023
- 资助金额:
$ 53.58万 - 项目类别:
Studentship
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
- 批准号:
10761044 - 财政年份:2023
- 资助金额:
$ 53.58万 - 项目类别:
Lifestyle, branched-chain amino acids, and cardiovascular risk factors: a randomized trial
生活方式、支链氨基酸和心血管危险因素:一项随机试验
- 批准号:
10728925 - 财政年份:2023
- 资助金额:
$ 53.58万 - 项目类别:
Single-molecule protein sequencing by barcoding of N-terminal amino acids
通过 N 端氨基酸条形码进行单分子蛋白质测序
- 批准号:
10757309 - 财政年份:2023
- 资助金额:
$ 53.58万 - 项目类别: